понедельник, 11 апреля 2016 г.

Gilead Sciences, Inc. (GILD) Rating Reiterated by Mizuho

Gilead Sciences, Inc. (GILD) Rating Reiterated by Mizuho


's stock had its "buy" rating reaffirmed by investment analysts at Mizuho in a research report issued on Sunday, Marketbeat.com reports. They presently have a $130.00 target price on the biopharmaceutical company's stock.



from Biotech News